Pathos

Series-B+
pathos.com AI & Machine Learning New York, United States Founded 2021 11-50
Total Funding $237M
Latest Round $237M Series-B+
Last Announced Oct 23, 2026
Investors 4 Backers
Decision Makers 6 Verified

About Pathos

Pathos is a biotechnology company that leverages AI to accelerate oncology drug development.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry AI & Machine Learning
Funding Stage Series-B+
Global Headquarters New York, United States
Year Founded 2021
Team Size 11-50
Tracked Since Oct 24, 2026

Web & Domain Identity

Official Website pathos.com
Domain Registered Date May 26, 1998

Social & Network Presence

X / Twitter Profile @lefkofsky
LinkedIn Corporate Company Profile

Company Milestones & Timeline

3 Events
  1. Capital Raise

    Raised $237,000,000 · Series-B

    Backed by Bristol-Myers Squibb

  2. Milestone

    Company founded

    New York, United States

  3. Milestone

    Website domain registered

    pathos.com

Investors & Backers

4
Bristol-Myers Squibb
Builders VC
NEA
Revolution Growth

Funding History

1 Round
Series-B equity · Oct 23, 2026

Round backers: Bristol-Myers Squibb

$237,000,000 axios.com

Founders & Leadership

3

Eric Lefkofsky

Founder

Work email & phone locked Unlock →

Iker Huerga

Chief Executive Officer

Work email & phone locked Unlock →

Ryan Fukushima

Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded AI & Machine Learning Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts